Kymera Therapeutics, Inc.
KYMR
54 insider filings · Latest: Oct 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2024 | Aug 26 8:25 PM | JEFFREY ALBERS | Proposed Sale | 5,000 | $47.78 | $238.9K | — | View → |
← Previous
Page 8 of 8
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | Mar 4 11:00 PM | Jared GollobChief Medical Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Bruce N. JacobsChief Financial Officer | Grant/Award | 35,300 | $90.10 | 35,300(D) | View → |
| Mar 2, 2026 | Mar 4 11:00 PM | Nello MainolfiDirector, Chief Executive Officer | Grant/Award | 215,000 | $90.10 | 215,000(D) | View → |
| Feb 25, 2026 | Feb 25 10:24 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 245,559(D) | View → |
| Feb 20, 2026 | Feb 20 10:30 PM | Pamela EspositoDirector | Option Exercise | 2,500 | $49.10 | 2,500(D) | View → |
| Jan 20, 2026 | Jan 20 11:30 PM | Pamela EspositoDirector | Option Exercise | 5,500 | $49.10 | 5,000(D) | View → |
| Dec 31, 2025 | Dec 31 10:23 PM | Nello MainolfiDirector, Chief Executive Officer | Option Exercise | 30,000 | $2.08 | 275,559(D) | View → |
← Previous
Page 3 of 3